Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nitta Gelatin Inc. (4977.T)
Osaka, JP
Established in Osaka, Japan, in 1918, Nitta Gelatin Inc. is a leading manufacturer and supplier primarily focused on gelatin and collagen products. The company's operations encompass the production and distribution of edible, pharmaceutical, and photographic gelatin, predominantly within the Japanese market. Utilizing raw materials like animal bones and skin, as well as fish scales and skin, they also develop a varied range of collagen-derived products. This includes industrial-grade gelatin for both food and pharmaceutical industries, alongside collagen peptides, which are known for their bioactive and bioregulatory characteristics, produced using proprietary proteolytic technology. Additionally, Nitta Gelatin provides other food ingredients and stabilizers vital for confectionery, desserts, delicatessen items, and chilled foods. They further extend their expertise to the medical field, supplying specialized collagen and medical gelatin to device manufacturers and research institutions for use as biomaterials in applications such as artificial skin and bone.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.86% | +1.03% | -6.45% | -15.54% | +3.07% | -4.48% | +47.67% | +57.80% | +84.59% | +55.91% | +149.26% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-1.8% Q1'26: +8.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+3.8% Q1'26: -61.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+13.5% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+12.3% ★ Q1'26: +10.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+14.1% ★ Q1'26: +10.6% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.98× ★ Q1'26: 1.05× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
31.91B
est: 32.40B (-1.5%)
|
36.89B
est: 37.60B (-1.9%)
|
36.58B
est: 35.65B (+2.6%)
|
37.78B
est: 37.60B (+0.5%)
|
36.46B
est: 36.50B (-0.1%)
|
34.54B
est: 34.60B (-0.2%)
|
30.55B
est: 31.20B (-2.1%)
|
31.78B
est: 30.80B (+3.2%)
|
39.19B
est: 39.40B (-0.5%)
|
40.42B
est: 40.30B (+0.3%)
|
38.75B
est: 39.60B (-2.2%)
|
37.50B
37.50B – 37.50B
-5.3% YoY
|
38.80B
38.80B – 38.80B
+3.5% YoY
|
40.70B
40.70B – 40.70B
+4.9% YoY
|
| EBITDA |
2.20B
est: 3.15B (-30.2%)
|
2.84B
est: 3.66B (-22.5%)
|
3.13B
est: 3.47B (-9.7%)
|
2.82B
est: 3.66B (-23.0%)
|
2.51B
est: 3.55B (-29.2%)
|
3.21B
est: 3.37B (-4.6%)
|
2.75B
est: 3.04B (-9.5%)
|
3.18B
est: 3.00B (+6.0%)
|
3.89B
est: 3.83B (+1.4%)
|
1.87B
est: 7.46B (-75.0%)
|
5.86B
est: 9.43B (-37.8%)
|
8.93B
8.93B – 8.93B
-5.3% YoY
|
9.24B
9.24B – 9.24B
+3.5% YoY
|
9.69B
9.69B – 9.69B
+4.9% YoY
|
| EBIT |
1.08B
est: 1.81B (-40.1%)
|
1.27B
est: 2.10B (-39.4%)
|
1.66B
est: 1.99B (-16.6%)
|
247.00M
est: 2.10B (-88.2%)
|
1.27B
est: 2.04B (-37.9%)
|
1.72B
est: 1.93B (-11.1%)
|
1.36B
est: 1.74B (-22.2%)
|
1.76B
est: 1.72B (+2.2%)
|
2.26B
est: 2.20B (+2.6%)
|
140.00M
est: 6.65B (-97.9%)
|
4.59B
est: 8.39B (-45.2%)
|
7.94B
7.94B – 7.94B
-5.3% YoY
|
8.22B
8.22B – 8.22B
+3.5% YoY
|
8.62B
8.62B – 8.62B
+4.9% YoY
|
| Net Income |
610.07M
est: 692.08M (-11.9%)
|
477.00M
est: 692.08M (-31.1%)
|
693.00M
est: 790.17M (-12.3%)
|
-615.00M
est: 593.99M (-203.5%)
|
989.00M
est: 988.16M (+0.1%)
|
-694.00M
est: -514.06M (-35.0%)
|
742.00M
est: 804.70M (-7.8%)
|
726.00M
est: 702.98M (+3.3%)
|
1.56B
est: 1.25B (+24.5%)
|
-1.85B
est: 1.20B (-253.8%)
|
3.16B
est: 2.40B (+31.6%)
|
3.20B
3.20B – 3.20B
+33.2% YoY
|
2.70B
2.70B – 2.70B
-15.6% YoY
|
2.50B
2.50B – 2.50B
-7.4% YoY
|
| SGA |
4.73B
est: 4.75B (-0.5%)
|
6.46B
est: 5.51B (+17.1%)
|
5.92B
est: 5.23B (+13.2%)
|
5.93B
est: 5.51B (+7.5%)
|
5.56B
est: 5.35B (+3.9%)
|
4.75B
est: 5.07B (-6.4%)
|
4.32B
est: 4.58B (-5.5%)
|
4.76B
est: 4.52B (+5.3%)
|
5.85B
est: 5.78B (+1.2%)
|
5.55B
est: 5.91B (-6.1%)
|
6.03B
est: 6.00B (+0.5%)
|
5.68B
5.68B – 5.68B
-5.3% YoY
|
5.88B
5.88B – 5.88B
+3.5% YoY
|
6.17B
6.17B – 6.17B
+4.9% YoY
|
| EPS |
33.20
est: 38.10 (-12.9%)
|
26.00
est: 38.10 (-31.8%)
|
37.74
est: 43.50 (-13.2%)
|
-33.47
est: 32.70 (-202.4%)
|
53.83
est: 54.40 (-1.0%)
|
-37.77
est: -28.30 (-33.5%)
|
40.98
est: 44.30 (-7.5%)
|
40.12
est: 38.70 (+3.7%)
|
85.97
est: 68.90 (+24.8%)
|
-101.93
est: 66.20 (-254.0%)
|
173.91
est: 132.10 (+31.7%)
|
175.90
175.90 – 175.90
+33.2% YoY
|
148.50
148.50 – 148.50
-15.6% YoY
|
137.50
137.50 – 137.50
-7.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-01 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - International Small Cap Value ETF DISV | 0.01% | 548.7K | 0.42% |
| 2 | Dimensional - International Small Cap ETF DFIS | 0.00% | 97.9K | 0.39% |
| 3 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | 11.1K | 0.24% |
| 4 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 110.1K | 0.22% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 51.2K | 0.28% |
| 6 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | — | 0.18% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akira Ando | Executive Officer, GM of Mgmt. Div. & System Solutions Department and Director | — | male |
| Hidenori Takemiya | President & Representative Director | — | male |
| Kazuya Hayashi | Executive Officer, GM of Production & Director | — | male |
| Kazuya Nakao | Executive Officer & Domestic Sales Manager - Sales Division | — | — |
| Noriyuki Tsuji | Executive Officer & Deputy GM of Production Headquarters and GM of Global Production Management Dept | — | — |
| Takuya Tanaka | Executive Officer | — | — |
| Yoshifumi Matsumoto | Executive Officer | — | male |
| Yoshihisa Sugimoto | Executive Officer, GM of Sales Headquarters & Overseas Sales and Director | — | male |
| Yosuke Hiraoka | Executive Officer & Director of the Research Institute | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4977.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
